These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9686628)

  • 41. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sclerosing peritonitis.
    Bowers VD; Ackermann JR; Richardson W; Carey LC
    Clin Transplant; 1994 Aug; 8(4):369-72. PubMed ID: 7949541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.
    Afthentopoulos IE; Passadakis P; Oreopoulos DG; Bargman J
    Adv Ren Replace Ther; 1998 Jul; 5(3):157-67. PubMed ID: 9686626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does sclerosing peritonitis induce MIA syndrome and generalized sclerosis?
    Basic-Jukic N; Kes P
    Perit Dial Int; 2005; 25(6):608-10. PubMed ID: 16411534
    [No Abstract]   [Full Text] [Related]  

  • 46. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Consequences of peritonitis episodes appearing late during peritoneal dialysis (PD) in patients able to continue PD.
    Selgas R; Paiva A; Bajo MA; Cirugeda A; Aguilera A; Díaz C; Hevia C
    Adv Perit Dial; 1998; 14():168-72. PubMed ID: 10649718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrafiltration failure in peritoneal dialysis. Causes and clinical consequences.
    Smit W; Parikova A; Krediet RT
    Minerva Urol Nefrol; 2005 Sep; 57(3):165-74. PubMed ID: 15986015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Peritoneal sclerosis in children under treatment with peritoneal dialysis].
    Moriya S; Koshino H; Iitaka K; Kasai N
    Nihon Jinzo Gakkai Shi; 2001 May; 43(5):378-83. PubMed ID: 11510225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peritoneal membrane structural and functional changes during peritoneal dialysis.
    Goffin E
    Semin Dial; 2008; 21(3):258-65. PubMed ID: 18363601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peritoneal dialysis.
    Teitelbaum I; Burkart J
    Am J Kidney Dis; 2003 Nov; 42(5):1082-96. PubMed ID: 14582053
    [No Abstract]   [Full Text] [Related]  

  • 52. Diagnosis characteristics and therapeutical options of infectious complications associated with peritoneal dialysis.
    Mihalache O; Doran H; Catrina E; Bobircă F; Mustatea P; Georgescu D; Pătrașcu T
    J Med Life; 2014; 7 Spec No. 3(Spec Iss 3):103-6. PubMed ID: 25870705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis and treatment of peritoneal membrane failure.
    Saxena R
    Pediatr Nephrol; 2008 May; 23(5):695-703. PubMed ID: 17891546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peritoneum: a noble membrane in long-term dialysis treatment.
    Barone RJ; Campora MI; Gimenez NS; Ramirez L; Santopietro M; Grbavac D; Pattin M; Panese SA
    Adv Perit Dial; 2009; 25():80-4. PubMed ID: 19886323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.
    Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J
    Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Smeby LC; Mjåland S; Dahl K; Berg KJ; Wessel Aas T
    Nephron; 1984; 38(4):238-47. PubMed ID: 6514073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The dialytic failure of the peritoneal membrane.
    Lupo A; Rugiu C; Lapolla A; Maiorca P; Aricó CN; Bernich P; Marcantoni C; Brezzi B; Maschio G
    Contrib Nephrol; 2001; (131):90-6. PubMed ID: 11125567
    [No Abstract]   [Full Text] [Related]  

  • 60. Pathophysiology and morphological clinical correlation in experimental and peritoneal dialysis-induced peritoneal sclerosis.
    Garosi G; Di Paolo N
    Adv Perit Dial; 2000; 16():204-7. PubMed ID: 11045294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.